Form 4: Pediatrix Director Michael Rucker Receives Equity Grant

Director Michael A. Rucker was granted 7,196 restricted shares of Pediatrix Medical Group, Inc. common stock.

Summary

• Director Michael A. Rucker acquired 7,196 shares of common stock.
• The shares were granted as part of the company's annual equity award program.
• The transaction occurred on May 7, 2026, at a price of $0 per share.
• Following this transaction, the director's total beneficial ownership is 66,297 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity compensation.
• Standard annual incentive compensation grant indicates normal corporate governance activity.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The restricted shares are scheduled to vest on May 7, 2027, subject to the terms of the 2008 Incentive Compensation Plan.

Industry Context

StockSavvy.ai notes that annual equity grants to non-employee directors are a standard practice in the healthcare services sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant is consistent with standard corporate governance practices for publicly traded companies in the medical services industry.
• The use of restricted stock units (RSUs) for director compensation is a common benchmark among mid-cap healthcare firms.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard annual compensation event.

Next Steps

• Vesting of the 7,196 restricted shares on May 7, 2027.

Key Dates

Keywords

Pediatrix, MD, Form 4, Insider Trading, Equity Grant, Director Compensation